MRK241129P117000
- 0.00
- 0.000.00%
Merck & Co Newsroom
S&P 500 and Nasdaq Hit Closing and Trading Highs Monday | Wall Street Today
Merck & Co Unusual Options Activity For December 02
Bernstein Maintains Merck & Co(MRK.US) With Hold Rating, Cuts Target Price to $110
December Starts With a Mixed Market | Live Stock
Bernstein Trims Price Target on Merck to $110 From $115
Merck (MRK.US) antibiotic combination has been approved for sale in China.
Merck (MRK.US) antibiotic combination has been approved for sale in China.
Catalyst Watch: November Jobs, OPEC+ Meeting, Marvell, Salesforce Earnings
Wednesday Ends With Index Decline | Wall Street Today
Dow Hits Another Record, Core PCE 2.8% as Expected | Live Stock
Trump Taps Jay Bhattacharya to Lead National Institutes of Health
S&P 500, Dow Hit Records, Trump Tariffs to Cost Hundreds of Billions | Wall Street Today
Merck Stock Up as Winrevair Meets Goal in Advanced PAH Study
Dow Falls After Record, Trump Talks Tariffs on Day One | Live Stock
Amgen, Boeing Share Losses Lead Dow's 200-Point Fall
Merck & Co. (MRK) Fell As It Faced Some Demand Headwinds In China
Daily short sale tracking: Nu Holdings's short volume increased by 25 million, with a short sale ratio of 31%
Dr. Reddy's Laboratories Launches Anti-Parasitic Drug Ivermectin
Jefferies Maintains Merck & Co(MRK.US) With Buy Rating, Raises Target Price to $150
Jefferies Reaffirms Their Buy Rating on Merck & Company (MRK)
Today's Analyst Rating | UnitedHealth Price Target Raised to $655 by RBC Capital, Citi Upgrades Chevron to Buy